1-109066173-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_005645.4(TAF13):c.166A>G(p.Ile56Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000104 in 1,613,022 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005645.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAF13 | NM_005645.4 | c.166A>G | p.Ile56Val | missense_variant | Exon 3 of 4 | ENST00000338366.6 | NP_005636.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAF13 | ENST00000338366.6 | c.166A>G | p.Ile56Val | missense_variant | Exon 3 of 4 | 1 | NM_005645.4 | ENSP00000355051.4 | ||
TAF13 | ENST00000692048.1 | c.166A>G | p.Ile56Val | missense_variant | Exon 3 of 5 | ENSP00000508876.1 | ||||
TAF13 | ENST00000461096.7 | c.52A>G | p.Ile18Val | missense_variant | Exon 3 of 4 | 5 | ENSP00000433883.2 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152160Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000439 AC: 11AN: 250304Hom.: 0 AF XY: 0.0000517 AC XY: 7AN XY: 135330
GnomAD4 exome AF: 0.000108 AC: 158AN: 1460862Hom.: 0 Cov.: 30 AF XY: 0.0000881 AC XY: 64AN XY: 726764
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152160Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74342
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.166A>G (p.I56V) alteration is located in exon 3 (coding exon 3) of the TAF13 gene. This alteration results from a A to G substitution at nucleotide position 166, causing the isoleucine (I) at amino acid position 56 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at